Medical Technology Stock Letter

BioInvest.com is the web home of the Medical Technology Stock Letter, an industry leading newsletter covering the biotech sector for almost thirty years.  Seeking information on FDA Approvals, Biotech Mergers & Acquisitions, Stock Picks, Long Investments and the occassional Short Sale?  Trying to stay on the cutting edge of scientific developments so you can stay ahead of the Markets? 

The Medical Technology Stock Letter is the source for Biotechnology news and investing advice.  Forget the pundits and the trends.  Here you find only experienced insight and the details that Wall Street doesn't want you to know.

Request a Free Issue then go to the Newsletter page to find out what's new at MTSL.

Subscribers, click here to log in or go directly to the Subscriber area.

Search BioInvest.com
Loading
Latest News from Yahoo! Finance

September 9, 2010

Transactions for Monday, September 13, 2010:

As mentioned above, using Monday’s prices, we will buy 1,000 September $5 puts of VVUS in the Model Portfolio and 1,000 September $5 puts of VVUS in the Trader’s Portfolio. We are also shorting 10,000 shares in the Model Portfolio. A 1% commission will be charged on each transaction.

Transactions completed Monday, August 30:

As indicated in the last issue, we made the following transactions in the Portfolios using the closing prices of Monday, August 30. A 1% commission was charged on each transaction.

In the Model Portfolio we sold: All of the CELG, ELN, GNVC, and MDCO. We also sold one half of the BMRN, INCY, ISIS, and ONXX positions.

In the Trader’s Portfolio we sold: All of the BMRN, CELG, ELN, GNVC, ISIS, and MDCO. We sold one half of INCY and ONXX.

In the Model Portfolio purchased 15,000 shares of ASTM, 4,000 shares of ALKS and shorted 10,000 shares of ARNA.

In the Trader’s Portfolio we purchased 2,000 shares of ALKS and shorted 5,000 shares of ARNA.